About this document

MS Drug Safety in Pregnancy: Key Insights by Fernando is a document available to read on EtoBox.

The article discusses the safety of disease-modifying drugs (DMDs) for multiple sclerosis (MS) during pregnancy, highlighting the need for women to consider discontinuing medication to avoid potential risks to their unborn child. It reviews existing animal and human studies on various DMDs, including IFN-β, glatiramer acetate, and fingolimod, while addressing the limitations of current research and the importance of effective pharmacovigilance. Recommendations for managing DMDs during pregnancy and breastfe

Author

Fernando

Language

EN